Belgian biopharmaceutical developer UCB, a more than three-decade Georgia investor, is doubling down on the state with a $2 billion commitment to domestic manufacturing in Gwinnett County. The company said last June that it would soon build a U.S. biologics factory with a $5 billion long-term impact, but company leaders were coy at the time … Read more
Category: Global Health
Sponsored Content
